Drug Profile
BSF 302146
Alternative Names: LU 302146Latest Information Update: 23 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott GmbH & Co. KG
- Class Antihypertensives; Benzhydryl compounds; Heart failure therapies; Pyrimidines
- Mechanism of Action Endothelin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension